tiprankstipranks
Trending News
More News >
C4 Therapeutics, Inc. (CCCC)
:CCCC
US Market

C4 Therapeutics (CCCC) Income Statement

Compare
493 Followers

C4 Therapeutics Income Statement

Last quarter (Q3 2024), C4 Therapeutics's total revenue was $5.18M, an increase of 58.75% from the same quarter last year. In Q3, C4 Therapeutics's net income was $-34.57M. See C4 Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 35.58M$ 20.76M$ 31.10M$ 45.78M$ 33.20M
Gross Profit
$ 35.58M$ -96.95M$ 23.52M$ 42.88M$ -44.27M
Operating Expenses
$ 155.20M$ 159.79M$ 160.63M$ 127.92M$ 93.64M
Depreciation and Amortization
$ 1.82M$ 7.74M$ 7.57M$ 2.91M$ 2.84M
EBITDA
$ -103.37M$ -122.10M$ -124.28M$ -78.84M$ -62.89M
Operating Income
$ -119.61M$ -139.03M$ -129.53M$ -82.13M$ -60.45M
Other Income/Expenses
$ 14.43M$ 7.82M$ 1.36M$ -1.76M$ -6.51M
Pretax Income
$ -105.19M$ -131.21M$ -128.18M$ -83.89M$ -66.96M
Net Income
$ -105.32M$ -132.49M$ -126.50M$ -86.04M$ -66.33M
Per Share Metrics
Basic EPS
$ -1.52$ -2.67$ -2.59$ -1.87$ -1.54
Diluted EPS
$ -1.52$ -2.67$ -2.59$ -1.87$ -1.54
Weighted Average Shares Outstanding
69.37M 49.64M 48.86M 46.04M 43.06M
Weighted Average Shares Outstanding (Diluted)
69.37M 49.64M 48.86M 46.04M 43.06M
Currency in USD

C4 Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis